Lymphedema Diagnostics Market Overview: Type & Applications, Industry Trends, Analysis & Forecasts, 2018-2027

 

Market Highlights
According to MRFR analysis, the global lymphedema diagnostics market is expected to record a CAGR of ~ 7.1% during the forecast period 2019 to 2025 and was valued at $ 22.6 million in 2018.
Lymphatic obstruction or lymphedema is a long-term condition in which excess fluid forms in the body tissue and causes swelling commonly called edema. It develops due to the damaged lymphatic system. Sometimes it even develops after breast cancer treatment.
The growth of the global lymphedema diagnostics market is driven by numerous factors such as the increased incidence of cancer, the high prevalence of lymphedema and the adoption of new diagnostic modalities. However, the short half-life of radiopharmaceuticals and the high cost of diagnostic tests are expected to hold back the growth of the market during the forecast period.
The global lymphedema diagnostics market is currently dominated by several market players. Key players are involved in expansion, acquisition and strategic partnerships to strengthen their market positions.
Request a Free Sample: https://www.marketresearchfuture.com/sample_request/8761
Regional Analysis
The market was divided, by region, into the Americas, Europe, Asia-Pacific, the Middle East and Africa.
The Americas are expected to hold the largest market share due to the high prevalence of lymphedema, the well-established healthcare sector and the presence of major players in this region. The Americas lymphedema diagnostics market has been further branched into North America and Latin America, with the North American market split into the United States and Canada.
The European lymphedema diagnostics market has been classified as Western Europe and Eastern Europe. The Western European market was further classified as Germany, France, the United Kingdom, Italy, Spain and the rest of Western Europe. The Asia Pacific lymphedema diagnostics market has been segmented into Japan, China, India, South Korea, Australia and the rest of Asia Pacific. Due to the increasing prevalence of cancer and the expansion of healthcare facilities, the market in Asia-Pacific is expected to be the fastest growing. The lymphedema diagnostics market in the Middle East and Africa has been divided into the Middle East and Africa.
Segmentation
The global lymphedema diagnostics market has been segmented by type, technology, disease type and end user.
The market, based on the type, has been divided into primary and secondary. Secondary lymphedema is likely to hold the highest market share in the global lymphedema diagnostics market due to the large population related to the presence of secondary lymphedema worldwide.
The global technology-based lymphedema diagnostics market has been segregated into lymphoscintigraphy, MRI, computed tomography, ultrasound and others. The lymphoscintigraphy segment is expected to hold the largest share in the market due to the large preference for testing.
The global disease type-based lymphedema diagnostics market has been segregated into cancer, inflammatory disease, cardiovascular disease, and others. The cancer segment is expected to hold the largest share in the market as a cancer treatment is one of the major factors causing lymphedema.
The end-user segments of the market are hospitals, diagnostic centers and others. The hospital segment is expected to hold the largest share of the market, as these are the primary places where patients receive diagnosis and treatment.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/lymphedema-diagnostics-market-8761

Key
Players Some of the major players in the global lymphedema diagnostics market are Siemens Healthineers, GE Healthcare, Stryker Corporation, Philips, Shimadzu Corporation, Canon, Inc., United Imaging Healthcare Co., Ltd., Hitachi, Ltd., Fluoptics and Esaote SPA.
FREE SAMPLE

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *